Prevention of Infection in the Obstetric PatientPrevention of Pertussis, Tetanus, and Diphtheria Among Pregnant, Postpartum Women, and InfantsGALL, STANLEY A. MD, FACOGAuthor Information Gynecology & Women’s Health, University of Louisville, Louisville, Kentucky The author declares that there is nothing to disclose. Correspondence: Stanley A. Gall, MD, FACOG, Gynecology & Women’s Health, University of Louisville, Louisville, KY 40202. E-mail: email@example.com. Clinical Obstetrics and Gynecology: June 2012 - Volume 55 - Issue 2 - p 498-509 doi: 10.1097/GRF.0b013e31824f3b38 Buy SDC Metrics Abstract Pertussis disease in the United States has been increasing since 1976 and many states are reporting epidemics. Pertussis is more severe in infants less than 3 months of age and is characterized by high hospital admission rates, apnea of the infant. The CDC recommends that Tdap be administered to all pregnant women after the 20th week of gestation to provide pertussis antibodies to the fetus which will offer protection against pertussis disease. Tdap is highly immunogenetic in the pregnant women and has an excellent safety profile. Tdap given to the postpartum patient and her cocoon family is an alternative strategy. © 2012 Lippincott Williams & Wilkins, Inc.